The R882H DNMT3A Mutation Associated with AML Dominantly Inhibits Wild-Type DNMT3A by Blocking Its Ability to Form Active Tetramers

Russler-Germain, David A., Spencer, David H., Young, Margaret A., Lamprecht, Tamara L., Miller, Christopher A., Fulton, Robert, Meyer, Matthew R., Erdmann-Gilmore, Petra, Townsend, R. Reid, Wilson, Richard K., Ley, Timothy J.·2014·Cancer Cell
DOI 10.1016/j.ccr.2014.02.010

Cited by (454)

Items 401–454 of 454

  1. The Role of DNA Methyltransferases in Normal and Malignant Hematopoiesis
    Staci L. Haney · 2016 · DigitalCommons@UNMC
  2. Co-corresponding Authorship
    Govindasamy Agoramoorthy · 2016 · Academic Radiology
  3. Gene enhancer deregulation and epigenetic vulnerability
    Rui Lu, Gang Greg Wang · 2016 · Oncoscience
  4. The Role of Cbx Proteins in Human Benign and Malignant Hematopoiesis
    Johannes Jung, Hein Schepers, Seka Lazare, Sonja C. Buisman, Ellen Weersing, Bertien Dethmers-Ausema, Karin Klauke, Lenja Bystrykh, Gerald de Haan · 2016 · Blood
  5. [Modification of DNA methylation in leukemia development].
    Anne Gao, Yayun Zheng, Ting Cheng · 2016 · PubMed Central
  6. Variants of DNMT3A cause transcript-specific DNA methylation patterns and affect hematopoietic differentiation
    Tanja Božić, Joana Frobel, Annamarija Raić, Fabio Ticconi, Chao‐Chung Kuo, Stefanie Heilmann‐Heimbach, Tamme Weyert Goecke, Martin Zenke, Edgar Jost, Ivan G. Costa et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  7. Discerning Drivers of Cancer: Computational Approaches to Somatic Exome Sequencing Data
    Runjun D. Kumar · 2018 · Open Scholarship Institutional Repository (Washington University in St. Louis)
  8. Tfh Lymphoma: Analysis of a RHOA Mutation & Establishment of a Pre-Clinical Model
    Rebecca L. Allchin · 2019 · Figshare
  9. Epigenetics changes of Brain Derived Neurotrophic Factor in case of Hypermethylation in Type 2 Diabetic Retinopathy
    Anuradha Agrawal · 2019 · International Journal for Research in Applied Science and Engineering Technology
  10. Tickt’s noch? 5-Methylcytosine und die Altersbestimmung
    Steve Hoffmann · 2020 · BIOspektrum
  11. Molecular Landscape of MDS
    Torsten Haferlach, Ines Schmidts · 2020 · Springer eBooks
  12. Genome-wide analysis of focal DNA hypermethylation in IDH -mutant AML samples
    Elisabeth R. Wilson, Nichole Helton, Sharon E. Heath, Robert S. Fulton, Jacqueline E. Payton, John Sutton Welch, Matthew J. Walter, Peter Westervelt, John F. DiPersio, Daniel C. Link et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  13. Мутации в ДНК-метилтрансферазе DNMT3A при остром миелоидном лейкозе
    Daria A. Khrabrova, Якубовская Марианна Геннадиевна, E. S. Gromova · 2021 · Biochemistry (Moscow)
  14. Epigenetic Mechanisms Governing the Differentiation of Glioblastoma Stem Cells
    Julia E. Jaramillo · 2020 · TSpace (University of Toronto)
  15. Computational analysis and characterization of dysregulated chromatin interactions and RNA biology in acute myeloid leukemia
    Lingshi Kong · 2021
  16. Molecular Signatures in Acute Myeloid Leukemia: From Diagnosis to Targeted Therapy and Drug Repositioning
    Nurdan Kelesoglu, Betul Karademir-Yilmaz, Kazım Yalçın Arğa · 2022 · Interdisciplinary cancer research
  17. Can dental problems be indicative of clonal hematopoiesis?
    Soichi Sano, Kenneth X. Walsh · 2024 · Cell Research
  18. Transcriptomic alterations including p53 pathway dysregulation prime DNMT3A mutant cells for transformation
    Erin Lawrence, Amali Cooray, Andrew J. Kueh, Martin Pál, Lin Tai, Alexandra L. Garnham, Connie S.N. Li Wai Suen, Hannah Kate Vanyai, Quentin A. Gouil, James Lancaster et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  19. Acute Myeloid Leukemia with deletion 5q is an epigenetically distinct subgroup defined by heterozygous loss of KDM3B
    Katherine A. Kelly, Linda Welte, Etienne Sollier, Anna Riedel, Fiona Brown-Burke, Michael Scherer, Harold N Keer, Mohammad Azab, Ekaterina Jahn, Hartmut Döhner et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  20. Stability and DNA Methyltransferase Activity of DNMT3A are Maintained by Ubiquitin-Specific Peptidase 11 (USP11) and Sumoylation Countering Degradation
    Taishi Yonezawa, Justine C. Rutter, Raghav Ramabadran, Venkatasubramaniam Sundaramurthy, Gandhar K. Datar, Mikolaj Michal Slabicki, Margaret A. Goodell · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  21. Multiple tumours of different lineages likely related to a DNMT3A pathogenic R688H variant
    Kheloud M. Alhamoudi, Meshael M. Alswailem, Balgees Alghamdi, Maram Alshuwaymi, Karla A. Peña‐Guerra, Stefan T. Arold, Hindi Al‐Hindi, Ali Saeed Alzahrani · 2025 · BMJ connections.
  22. Cross-resistance of Belinostat and Romidepsin in Non–T Follicular Helper Peripheral T-cell Lymphoma Models Suggests Subtype-Specific Implications for Belinostat-CHOP
    Jacob C. Pantazis, Adam Christopher Palmer · 2025 · Molecular Cancer Therapeutics
  23. Additional file 8 of DNA methylation regulator-mediated modification patterns and risk of intracranial aneurysm: a multi-omics and epigenome-wide association study integrating machine learning, Mendelian randomization, eQTL and mQTL data
    Aierpati Maimaiti, Mirzat Turhon, Aimitaji Abulaiti, Yilidanna Dilixiati, Fujunhui Zhang, Aximujiang Axier, Kaheerman Kadeer, Zhang, Yisen, Aisha Maimaitili, Yang, Xinjian · 2024 · Figshare
  24. Additional file 7 of DNA methylation regulator-mediated modification patterns and risk of intracranial aneurysm: a multi-omics and epigenome-wide association study integrating machine learning, Mendelian randomization, eQTL and mQTL data
    Aierpati Maimaiti, Mirzat Turhon, Aimitaji Abulaiti, Yilidanna Dilixiati, Fujunhui Zhang, Aximujiang Axier, Kaheerman Kadeer, Zhang, Yisen, Aisha Maimaitili, Yang, Xinjian · 2024 · Figshare
  25. Additional file 1 of DNA methylation regulator-mediated modification patterns and risk of intracranial aneurysm: a multi-omics and epigenome-wide association study integrating machine learning, Mendelian randomization, eQTL and mQTL data
    Aierpati Maimaiti, Mirzat Turhon, Aimitaji Abulaiti, Yilidanna Dilixiati, Fujunhui Zhang, Aximujiang Axier, Kaheerman Kadeer, Zhang, Yisen, Aisha Maimaitili, Yang, Xinjian · 2024 · Figshare
  26. Additional file 5 of DNA methylation regulator-mediated modification patterns and risk of intracranial aneurysm: a multi-omics and epigenome-wide association study integrating machine learning, Mendelian randomization, eQTL and mQTL data
    Aierpati Maimaiti, Mirzat Turhon, Aimitaji Abulaiti, Yilidanna Dilixiati, Fujunhui Zhang, Aximujiang Axier, Kaheerman Kadeer, Zhang, Yisen, Aisha Maimaitili, Yang, Xinjian · 2024 · Figshare
  27. Additional file 6 of DNA methylation regulator-mediated modification patterns and risk of intracranial aneurysm: a multi-omics and epigenome-wide association study integrating machine learning, Mendelian randomization, eQTL and mQTL data
    Aierpati Maimaiti, Mirzat Turhon, Aimitaji Abulaiti, Yilidanna Dilixiati, Fujunhui Zhang, Aximujiang Axier, Kaheerman Kadeer, Yisen Zhang, Aisha Maimaitili, Yang, Xinjian · 2024 · Figshare
  28. Additional file 3 of DNA methylation regulator-mediated modification patterns and risk of intracranial aneurysm: a multi-omics and epigenome-wide association study integrating machine learning, Mendelian randomization, eQTL and mQTL data
    Aierpati Maimaiti, Mirzat Turhon, Aimitaji Abulaiti, Yilidanna Dilixiati, Fujunhui Zhang, Aximujiang Axier, Kaheerman Kadeer, Zhang, Yisen, Aisha Maimaitili, Yang, Xinjian · 2024 · Figshare
  29. Additional file 4 of DNA methylation regulator-mediated modification patterns and risk of intracranial aneurysm: a multi-omics and epigenome-wide association study integrating machine learning, Mendelian randomization, eQTL and mQTL data
    Aierpati Maimaiti, Mirzat Turhon, Aimitaji Abulaiti, Yilidanna Dilixiati, Fujunhui Zhang, Aximujiang Axier, Kaheerman Kadeer, Zhang, Yisen, Aisha Maimaitili, Yang, Xinjian · 2024 · Figshare
  30. Additional file 2 of DNA methylation regulator-mediated modification patterns and risk of intracranial aneurysm: a multi-omics and epigenome-wide association study integrating machine learning, Mendelian randomization, eQTL and mQTL data
    Aierpati Maimaiti, Mirzat Turhon, Aimitaji Abulaiti, Yilidanna Dilixiati, Fujunhui Zhang, Aximujiang Axier, Kaheerman Kadeer, Zhang, Yisen, Aisha Maimaitili, Yang, Xinjian · 2024 · Figshare
  31. Additional file 1 of Hematopoietic differentiation persists in human iPSCs defective in de novo DNA methylation
    Olivia Cypris, Julia Franzen, Joana Frobel, Philipp Glück, Kuo, Chao-Chung, Stephani Schmitz, Selina Nüchtern, Martin Zenke, Wolfgang Wagner · 2022 · Figshare
  32. Convergent DNA methylation abnormalities at enhancers and bivalent promoters in human growth disorders
    Marie E. S. Wheeler, Yoshiko Takahashi, Jihye Lee, Camille T. Perez, X. Chen, Yuri Lee, Zachary S. Pope, Daniella Lu, Marcus Seldin, Ivan Marazzi et al. · 2025 · Epigenetics & Chromatin
  33. Unraveling the Involvement of Epigenetics in Acute Myeloid Leukemia (AML): Focusing on Epigenetic Treatments in AML
    Antonio Beato, Gregorio Favale, Daniela Carannante, Lucia Altucci, Vincenzo Carafa · 2026 · Genetics.
  34. Meeting report: 10th Annual Canadian Conference on Epigenetics
    Shaghayegh Nouruzi, Sabrina Grégoire, Mathieu Lupien, Martin Hirst · 2026 · Biochemistry and Cell Biology
  35. Genetic variation and inflammation intersections: GATA2- and RUNX1-linked mechanisms of blood pathogenesis
    Vu L. Tran, Kirby D. Johnson, Emery H. Bresnick · 2026 · Experimental Hematology
  36. Local Promoter Methylation Disorder algorithm reveals bidirectional epigenetic disruption in DNMT3A-mutated AML and predicts azacitidine treatment response
    Xin Liu, Shuqiang Cheng, Benfan Lin, Miaomiao Cui · 2026 · Frontiers in Oncology
  37. Pathology of Methylation, Demethylation, and Methylated DNA Binding Machinery
    О. А. Земляная, V. V. Strelnikov, Dmitry V. Zaletaev · 2026 · Molecular Biology
  38. GNAS et empreinte parentale : Caractérisation des GNAS-miRNAs et d’une nouvelle DMR
    Patrick Hanna · 2018 · theses.fr (ABES)
  39. Conséquences cliniques et moléculaires de la marque H3K27 me3 HIST1 dans les leucémies aigües myéloïdes sans anomalies cytogénétiques
    Sylvain Garciaz · 2018 · theses.fr (ABES)
  40. Des inhibiteurs de méthyltransférases de l'ADN au développement de sondes chimiques pour l'identification de modulateurs épigénétiques dérégulés dans les cancers
    Dany Pechalrieu · 2017 · theses.fr (ABES)
  41. Marqueurs moléculaires ciblés pour le pronostic et le traitement des corticosurrénalomes : de la génomique à la médecine personnalisée
    Anne Jouinot · 2020 · theses.fr (ABES)
  42. Développement de stratégies innovantes pour cibler la méthylation de l’ADN dans les cancers
    Alexandra Serhouni · 2021 · theses.fr (ABES)
  43. Biochemical, biophysical and structural study of proteins associated to human diseases : tcDAC2 and ADAT complex
    Elizabeth Ramos‐Morales · 2021 · theses.fr (ABES)
  44. À la rencontre des "readers" de l'ADN méthylé
    Diane Erdmann · 2021 · theses.fr (ABES)
  45. Rôle du dosage des facteurs de transcription dans l'initiation des leucémies aiguës mégacaryoblastiques pédiatriques par la fusion ETO2-GLIS2
    Marie Baille · 2024 · theses.fr (ABES)
  46. Recent Advances in Searching for DNMT Inhibitors and Their Potential Application in Treating Human Diseases
    Anatoly A. Bulygin, Anastasiia T. Davletgildeeva, Nikita A. Kuznetsov · 2026 · International Journal of Molecular Sciences
  47. Integrating ex vivo drug sensitivity and genetic mutation analysis improves prediction of chemotherapy response in acute myeloid leukemia
    Wei Li, Min Ji, Wei Li, ying heng zhou, Ruinan Jia, Xin Wen, Shumin Jin, Yiping Hao, Min Dai, Shumei Xu et al. · 2026 · Functional & Integrative Genomics
  48. Hypomethylation of FAM83A in lung adenocarcinoma mirrors an epigenetic signature of airway cell differentiation states
    Camille Wangermez, François Michel Carlier, Marylène Lecocq, Charles Pilette, Charles De Smet · 2026 · Discover Oncology
  49. Roles of DNA methyltransferases in hematopoiesis and hematologic malignancies
    Xiaoyue Gao, Lixin Rui · 2026 · Genes & Diseases
  50. Multidomain interaction governs the filamentous assembly of the dominant-negative DNMT3A R882H mutant
    Jianbin Chen, Jiuwei Lu, Zhixu Long, Sol Yoon, Megan Fukunaga, Jikui Song · 2026 · Proceedings of the National Academy of Sciences
  51. Retrotransposable element derepression distinguishes DNMT3A-mutant from TET2-mutant clonal haematopoiesis
    Maroof Hasan, Sylvia Durandeau, I. Richard Thompson, Hanae Roussotte, Yi-Ting Tsai, Nogayhan Seymen, Sıla Gerlevik, Nicholas Bianchini, Khadijeh Alishah, Merilyn M Albuquerque et al. · 2026 · GeroScience
  52. Silent, but not innocent: the emerging role of clonal hematopoiesis in predicting therapy-related myeloid neoplasms
    Şerife Emre Ünsal · 2026 · Frontiers in Oncology
  53. Epigenetics in development, disease, and therapy: from mechanisms to clinical interventions
    Yixuan Ren, Lei Yang, Boyi Fei, Rong Guo, Junran Huang, Zhenghao Xu, Ruoran Wang, Pinqi Zhang, Dandan Cao, Pan Chen et al. · 2026 · Science China Life Sciences
  54. BindingDB Entry 50013735: A novel class of selective non-nucleoside inhibitors of human DNA methyltransferase 3A.
    BindingDB · 2022 · UC San Diego